Pediatric posttraumatic seizures: epidemiology, putative mechanisms of epileptogenesis and promising investigational

Kimberly D Statler1

  • 1Division of Critical Care, Department of Pediatrics, The University of Utah School of Medicine, Salt Lake City, Utah 84158-0289, USA. kim.statler@hsc.utah.edu

Developmental Neuroscience
|September 1, 2006
PubMed

Insights

Pediatric traumatic brain injury (TBI) can cause seizures and epilepsy, impacting functional outcomes. Understanding the mechanisms behind these seizures is crucial for developing effective preventive therapies.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Epileptology

Background:

  • Posttraumatic seizures and epilepsy are frequent complications in children with traumatic brain injury (TBI).
  • These neurological conditions are associated with poorer functional outcomes in pediatric TBI survivors.
  • The underlying mechanisms driving epileptogenesis following pediatric TBI are not well understood.

Purpose of the Study:

  • To review the current epidemiology of pediatric posttraumatic seizures.
  • To discuss the proposed mechanisms involved in posttraumatic epileptogenesis.
  • To highlight recent advancements in experimental research on pediatric posttraumatic seizures and epilepsy.

Main Methods:

  • Literature review of epidemiological data on pediatric posttraumatic seizures.
  • Synthesis of current hypotheses regarding the pathogenesis of posttraumatic epilepsy.
  • Summary of findings from recent experimental studies investigating therapeutic interventions.

Main Results:

  • Epidemiological data indicate a significant incidence of seizures post-TBI in children.
  • Several putative mechanisms, including excitotoxicity and neuroinflammation, are implicated in epileptogenesis.
  • Experimental models show promise for identifying novel preventive strategies.

Conclusions:

  • Pediatric posttraumatic seizures and epilepsy represent a significant clinical challenge with limited therapeutic options.
  • Further research into the complex mechanisms of epileptogenesis is essential.
  • Promising experimental findings offer hope for future preventive therapies for post-traumatic epilepsy in children.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...